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25 Abstract (Word count: 250) 
26 Background: Access to quality hospital care is a persistent problem for rural patients. Little is known 
27 about rural-urban disparities in in-hospital outcomes for end-stage liver disease (ESLD) patients. We 
28 aimed to determine whether rural ESLD patients experienced higher in-hospital mortality than urban 
29 patients, and whether disparities were attributable to the rurality of the patient or the center. 
30 Methods: This was a retrospective study of admissions in the National Inpatient Sample, a population -
31 based sample of hospitals in the United States. Admissions were included if they were from adult patients 
32 that had an ESLD-related admission defined from ICD-9 codes between January 2012 and December 
33 2014. The primary exposures of interest were patient-level rurality and hospital-level rurality. The main 
34 outcome was in-hospital mortality. We stratified our analysis by disease severity score. 
35 Results: After accounting for patient- and hospital-level covariates, ESLD admissions to rural hospitals in 
36 every category of disease severity had significantly higher odds of in-hospital mortality than admissions 
37 to urban hospitals; those with moderate or major risk of dying had more than twice the odds of in-hospital 
38 mortality (OR for moderate: 2.41, 95% CI: 1.62, 3.59; OR for major: 2.49, 95% CI: 1.97, 3.14). There 
39 was no association between patient-level rurality and mortality in adjusted models. 
40 Conclusions: ESLD patients admitted to rural hospitals had an increased odds of in-hospital mortality 
41 compared to those admitted to urban hospitals; differences were not attributable to patient-level rurality. 
42 Our results suggest that interventions to improve outcomes in this population should focus on the health 
43 systems level.





49 Patients with end-stage liver disease (ESLD) are often critically ill and require hospital admission for 
50 the management of complications. Consistent with a general trend of improvement in outcomes across 
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52 cirrhotic patients over the past decade4,5. This trend has been attributed to improved medical care aimed at 
53 prolonging life among cirrhotic patients and increased attention to health care delivery, including quality 
54 improvement initiatives6.  
55 Characteristics of the treating hospital play a large role in the outcomes of cirrhotic patients. In-
56 patient mortality varies substantially among hospitals7, and is partially attributable to differences in 
57 resource intensity at the hospital level8. Little is known about treatment outcomes in rural hospitals, where 
58 outcomes for other conditions – such as acute myocardial infarction and congestive heart failure - are 
59 known to be inferior9. The quality of rural hospital care is particularly relevant for patients with ESLD, as 
60 rural areas experience a disproportionate burden of ESLD mortality10. Improving outcomes for these 
61 patients requires consideration of both the patient- and health systems-level factors that affect care in rural 
62 areas.
63 To clarify the role of hospital setting on outcomes among ESLD patients, we used national-level 
64 hospital admissions data to examine whether rural ESLD patients experienced higher in-hospital mortality 
65 than urban patients. We also sought to discern whether observed disparities were primarily attributable to 
66 the rurality of the patient or to the center. Finally, we examined patterns of intensity of care that may 
67 potentially explain observed differences in outcomes.
68 Methods:
69 Data Source
70 This study was a secondary analysis of the 2012-2014 National Inpatient Sample (NIS), collected 
71 as a part of the Healthcare Cost and Utilization Project (HCUP) at the Agency for Healthcare Research 
72 and Quality. The NIS is a 20-percent stratified random sample of discharge records from general, 
73 community, and academic medical centers in the U.S. from 46 participating states; patients admitted to 
74 long-term care or rehabilitation facilities are not represented in the NIS. NIS data can be weighted to 
75 represent national estimates of health care utilization, access, charges, quality, and outcomes11.
76 Study Population
77 The unit of analysis was hospital admission. Admissions were classified on the basis of ICD-9 
78 diagnosis codes into three groups: cirrhosis (571.2, 571.5), portal hypertensive complications (portal 
79 hypertension [572.3], ascites [78959], hepatic encephalopathy [572.2], upper gastrointestinal bleed 
80 [456.0, 456.2, 578.0, 578.1, 578.9], or hepatorenal syndrome [572.4]), or primary liver tumor (155.0). 
81 Admissions were considered ESLD-related if they met one of three criteria: 1) primary diagnosis of 
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83 hypertensive complications, with a secondary diagnosis of cirrhosis, or 3) primary liver tumor as either 
84 the primary or secondary diagnosis. This algorithm has been previously shown to have a high positive 
85 predictive value for identifying ESLD patients12. Admissions were included if they were from adult 
86 patients (over 18 years of age) that had an ESLD-related admission between January 1st, 2012 and 
87 December 31st, 2014. 
88 Study Variables
89 The primary outcome was in-hospital mortality, obtained from the discharge disposition of the 
90 patient. Patients with the outcome were those who died while admitted to the hospital. Patients without 
91 the outcome were alive at the time of discharge, even if they died outside of the hospital later. As a 
92 secondary outcome, we used ICD-9 procedural codes to determine whether an admission had a 
93 paracentesis (549.1) or endoscopy (451.3, 441.3, 422.3, 423.3) performed. Paracentesis and endoscopy 
94 serve diagnostic and therapeutic roles in ESLD patients with suspected peritonitis and gastrointestinal 
95 bleeding.
96 The primary exposures of interest were patient-level rurality, assessed using the county of patient 
97 residence, and hospital-level rurality. Patient rurality was assessed using the National Center for Health 
98 Statistics classification scheme for counties, and dichotomized to rural counties (micropolitan or non-core 
99 counties) and urban counties (counties in metropolitan areas of greater than 50,000). Hospital rurality was 
100 based on the Core Based Statistical Area (CBSA) of the hospital. Hospitals with a CBSA type of 
101 micropolitan or non-core were considered rural, while urban non-teaching and teaching hospitals were 
102 collapsed into one urban category. We assessed whether this affected results in a sensitivity analysis that 
103 compared rural hospitals and urban, non-teaching hospitals to urban teaching hospitals. 
104 As patients with more severe disease tend both have a higher risk of mortality and to self-select or 
105 be transferred into hospitals with more resources, we stratified our analysis by disease severity in order to 
106 account for this potential bias. Disease severity was classified according to the All Patient Refined 
107 diagnosis-related group (APR-DRG) risk of mortality scheme, developed for HCUP databases and 
108 previously found to be the strongest predictors of in-hospital mortality among cirrhosis admissions13. The 
109 APR-DRG is a four-category scale (1 = “Minor risk of dying”, 2 = “Moderate risk of dying”, 3 = “Major 
110 risk of dying”, 4 = “Extreme risk of dying”). Patient-level covariates collected at the time of hospital 
111 admission included age, sex, race, primary payer, zip-code level income, Elixhauser comorbidity index, 
112 and whether the patient was transferred into the hospital. Hospital-level covariates included region and 
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115 We used the provided survey weights for NIS to account for the stratified sampling. Descriptive 
116 statistics for our population, including means, medians, and proportions, were calculated. Bivariate 
117 analyses were used to compare discharge-level categorical variables by patient-level and hospital-level 
118 rurality. We used multivariable logistic regression to estimate the association between rurality and in-
119 hospital mortality, accounting for patient-level and hospital-level factors. Generalized estimating 
120 equations (GEE) were used to account for correlations between patients in the same hospitals. We chose 
121 to use GEE since it is considered an appropriate method to obtain the average effect of both patient- and 
122 hospital-level covariates on an outcome in a population in the presence of correlated data14. All models 
123 were stratified by APR-DRG mortality risk group. Due to our interest in identifying the relative 
124 importance of patient-level and hospital-level rurality, we examined effects one at a time. First, we 
125 separately estimated the crude association between hospital rurality (Model 1A) and patient rurality 
126 (Model 1B) with in-hospital mortality. Second, we included both hospital rurality and patient rurality in 
127 the model (Model 2). Finally, we included all identified patient- and hospital-level covariates in a fully 
128 adjusted model (Model 3). To accomplish our secondary aim, we used Chi-square tests to compare the 
129 frequency of receiving paracentesis, endoscopy, or either by hospital rurality. We then included 
130 paracentesis and endoscopy into the fully-adjusted model above to determine whether their inclusion 
131 explained the association between rurality and in-hospital mortality (Model 4). We conducted a complete 
132 case analysis; 8,685 patients (7.8%) were excluded for missing covariate or outcome information. All 
133 analyses were conducted in SAS 9.4.
134 Results:
135 We identified 111,044 ESLD-related admissions between January 1st, 2012 and December 31st, 
136 2014. Demographic characteristics are provided in Table 1. Approximately 16% of ESLD admissions 
137 resided in a rural area (N = 17,559), while 8% of admissions were at a rural hospital (N = 8,992). 
138 Admissions were predominantly male (66%, N = 7372,839) and white (64%, N = 67,815), with a mean 
139 age of 60 (SD = 26 years). Medicare was the most frequent primary payer (43%, N = 47,478), followed 
140 by Medicaid (23%, N = 25,2089) and private insurance (22%, N = 24,332).  Approximately one-third of 
141 ESLD admissions were patients who lived in zip codes in the lowest income quartile (33%, N = 36,073). 
142 The South was the most common hospital region of admissions (40%, N = 44,737), and most admissions 
143 were to large hospitals (61%, N = 67,596). Approximately 7% of ESLD admissions resulted in an in-
144 hospital death (N = 7,178), and over half of the sample was at a major or extreme risk of dying as 
145 measured by the APR-DRG mortality risk classification (60%, N = 66,434) (Table 1). 
146 Demographic characteristics varied by both hospital-level and patient-level rurality (Table 2). 
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148 admissions among patients who lived in rural areas were to urban hospitals. Admissions to rural hospitals 
149 were more likely to be white (82% vs. 62%), have Medicare as the primary payer (51% vs. 42%), and live 
150 in zip codes in the lowest income quartile (54% vs. 32%). Over half of admissions to rural hospitals were 
151 in the South (52% vs. 39%). Admissions to rural hospitals were less likely to be at an extreme risk of 
152 dying (12% vs. 17%) or major risk of dying (38% vs. 43%). The crude difference in in-hospital mortality 
153 among admissions to rural hospitals was small (7% vs. 6%). Admissions to rural hospitals were more 
154 likely to be transferred to another short-term facility (7.8% vs. 2.7%) or to a skilled nursing facility 
155 (15.9% vs. 14.6%) than admissions to rural hospitals. Admissions to rural hospitals less likely than 
156 admissions to urban hospitals to have portal hypertension (27.7% vs. 37.8%) or a primary liver tumor 
157 (18.1% vs. 28.9%) but more likely to have hepatic encephalopathy (43.4% vs. 33.9%). Admissions to 
158 rural hospitals had a shorter mean length of stay than admissions to urban hospitals (4.4 days vs. 5.6 
159 days). Demographic and clinical characteristics among patients living in rural areas were essentially 
160 identical to admissions to rural hospitals with the exception of disease severity, comorbidity score, and 
161 portal hypertensive complications; the distribution of these characteristics was similar between rural and 
162 urban patients.
163 Among rural patients, 47.6% were admitted to a rural hospital, and 52.4% were admitted to an 
164 urban hospital. Among rural patients, admissions to rural hospitals were more likely to have Medicaid 
165 (50.8% vs. 44.2%), to live in a zip code in the lowest quartile of income (56.0% vs. 53.3%) and to live in 
166 the Northeast (12.4% vs. 6.1%) than admissions to urban hospitals. There were substantial differences in 
167 admission location among rural patients by disease severity, with admissions to rural hosptials less likely 
168 to be at extreme (11.9% vs. 21.4%) or major (39.5% vs. 43.2%) risk of dying. Similar to the overall 
169 population, among rural patients those admitted to rural hospitals were less likely to have portal 
170 hypertension (27.5% vs. 41.7%) or a primary liver tumor (18.2% vs. 26.7%) but more likely to have 
171 hepatic encephalopathy (43.6% vs. 34.0%). While there was not a meaningful difference in length of stay 
172 between rural and urban patients (5.2 days vs. 5.6 days), among rural patients, those in rural hospitals had 
173 a shorter length of stay than those in urban hospitals (4.4 days vs. 5.9 days). Rural patients seen in rural 
174 hospitals had a lower comorbidity score than rural patients seen in urban hospitals (11.8 vs. 13.3). 
175 In stratified bivariate analyses (Figure 2), hospital rurality was significantly associated with in-
176 hospital mortality among every category of disease severity. Among admissions at minor, moderate, or 
177 major risk of dying, admissions to rural hospitals had double the proportion of in-hospital mortality (2% 
178 vs. 1%, 2% vs. 1%, 6% vs. 3%, respectively).  Patient rurality was significantly associated with in-
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180 mortality (p = 0.86). When limited to admissions to urban hospitals, there were no statistically significant 
181 differences in in-hospital mortality between rural and urban patients in any category of disease severity. 
182 The multivariable logistic regression analyses examining the association between rurality and in-
183 hospital mortality, accounting for other patient- and hospital-level covariates, are presented in Table 3. 
184 Model 1 presents the crude association of both hospital-level and patient-level rurality with in-hospital 
185 mortality. Rural admissions of either classification had significantly increased odds of in-hospital 
186 mortality than urban patients, with the exception of rural patients at an extreme risk of dying (OR: 0.99, 
187 95% CI: 0.91, 1.08). In Model 2, we examined the association of hospital-level and patient-level rurality 
188 on in-hospital mortality together. Among patients at a minor risk of dying, there were no significant 
189 associations between rurality and in-hospital mortality. Among patients at a moderate or major risk of 
190 dying, admissions to rural hospitals had over twice the odds of experiencing in-hospital mortality as 
191 patients in urban hospitals (Moderate OR: 2.12; 95% CI: 1.47, 3.05; Major OR: 2.16, 95% CI: 1.75, 
192 2.66); the association between patient-level rurality and in-hospital mortality was not significant 
193 (Moderate OR: 1.14, 95% CI: 0.82, 1.58; Major OR: 0.97, 95% CI: 0.82, 1.17). 
194 In Model 3, after adjustment for age, race, sex, comorbidity index, insurance, zip code-level 
195 income, transfer status, region, and hospital bed size, there was a significant association between hospital 
196 rurality and in-hospital mortality in every stratum of disease severity. The strength of the association 
197 decreased as disease severity increased; admissions among patients with a minor risk of dying had nearly 
198 three times the odds of in-hospital mortality at rural hospitals than at urban hospitals (OR: 2.73, 95% CI: 
199 1.20, 6.22). Admissions at rural hospitals at a moderate or major risk of dying had more than twice the 
200 odds of experiencing in-hospital mortality as admissions to urban hospitals (OR for moderate risk: 2.41, 
201 95% CI: 1.62, 3.59; OR for major risk: 2.49, 95% CI: 1.97, 3.14). Among patients who were at an 
202 extreme risk of dying, admissions to rural hospitals had a 32% increased odds of in-hospital mortality 
203 compared to urban hospitals (95% CI: 1.11, 1.58), even after adjustment for patient- and hospital-level 
204 covariates. There were no significant associations between patient-level rurality and likelihood of in-
205 patient hospital mortality in any strata of disease severity. 
206 Table 4 presents the frequency of access to liver-disease specific procedures including 
207 paracentesis and endoscopy by hospital-level rurality, stratified by disease severity. For each procedure 
208 and in every strata of disease severity, with the exception of admissions at a minor risk of death, 
209 admissions to urban hospitals were statistically significantly more likely to have the procedure than 
210 admissions to rural hospitals.  Inclusion of paracentesis and endoscopy to the fully-adjusted model only 
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212 The attenuation was strongest for patients in the moderate (OR: 2.15, 95% CI: 1.43, 3.23) and major (OR: 
213 2.29, 95% CI: 1.81, 2.89) risk categories. 
214 In a sensitivity analysis, we compared rural admissions and urban non-teaching admissions to 
215 urban teaching hospitals, accounting for the covariates described above. In every strata of disease severity 
216 except for severe disease, admissions to rural hospitals were significantly more likely to experience in-
217 hospital mortality than admissions to urban teaching hospitals (OR for minor risk: 2.82, 95% CI: 1.18, 
218 6.74; OR for moderate risk: 2.73, 95% CI: 1.78, 4.19; OR for major risk: 2.39, 95% CI: 1.88, 3.04; OR 
219 for extreme risk: 1.15, 95% CI: 0.96, 1.38). Admissions to urban non-teaching hospitals also had a 
220 significantly higher likelihood of in-hospital mortality among patients at a moderate or major risk of 
221 dying, although the magnitude of the association was lower (OR for moderate risk: 1.89, 95% CI: 1.49, 
222 2.42; OR for major risk: 1.28, 95% CI: 1.14, 1.45). We also conducted a sensitivity analysis to evaluate 
223 whether results differed among the Medicare population or after adjustment for portal hypertensive 
224 complications or primary liver tumor, and found no significant differences (data not shown). 
225 To explore whether the effect of hospital location on mortality among rural patients could be 
226 explained by differences in referral patterns to urban hospitals (for example, if patients retained in rural 
227 hospitals were sicker or had lower socioeconomic status), we compared demographic and clinical 
228 characteristics between rural patients admitted to rural hospitals and rural patients admitted to urban 
229 hospitals (Supplementary Table 1). Rural patients admitted to rural hospitals were more likely to live in 
230 the lowest income zip codes (56.7% vs. 53.3%), have Medicare (50.8% vs. 44.2%), and be at minor (9.3% 
231 vs. 5.0%) or moderate (39.3% vs. 30.5%) risk of dying compared to rural patients admitted to urban 
232 hospitals. On average, rural patients admitted to rural hospitals were older (60.7 years vs. 58.8 years) but 
233 had a lower comorbidity index (11.8 vs. 13.3) compared to those admitted to urban hospitals. Based on 
234 these findings, it does not appear that rural patients in rural hospitals are not being referred to urban 
235 hospitals because of futility, as patients in rural hospitals have less severe disease (based on APR-DRG 
236 mortality risk) and similar comorbidity scores. Socioeconomic status could play a role in referral, as rural 
237 patients in rural hospitals had a higher proportion of patients in the lowest income zip codes, but the 
238 absolute difference between the two groups appears to be small and not likely to explain our findings.
239 Discussion:
240 In this analysis of a representative sample of ESLD admissions in the United States, we found 
241 that admission to a rural hospital, compared to an urban hospital, was associated with increased in-
242 hospital mortality, independent of patient-level rurality and other covariates. This association was 
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244 than twice the odds of experiencing in-hospital mortality as their urban counterparts, and was not 
245 explained by receipt of paracentesis or endoscopy. After accounting for hospital-level rurality, patient-
246 level rurality was not significantly associated with in-hospital mortality in any strata of disease severity. 
247 Our findings are relevant to the 1,800 rural community hospitals in the United States15, and imply that 
248 interventions to improve outcomes among rural ESLD patients may need to focus on intensity or quality 
249 of care at the health system level. As nearly half of the ESLD admissions in our study were covered by 
250 Medicare, and similar associations between hospital rurality and mortality were observed in the Medicare 
251 population, our findings may also be relevant to the Centers for Medicare and Medicaid Services. 
252 Rural areas in the U.S. have experienced higher mortality rates and excess death for the past two 
253 decades16. While prevalence estimates for ESLD are unavailable, rural areas have higher age-adjusted 
254 ESLD mortality rates than urban areas10. However, in our study, rural patients made up 15.3% of ESLD 
255 admissions despite making up 19.3% of the U.S. population. This underrepresentation in admissions, 
256 combined with an overrepresentation in mortality, signals that that there may be a disparity in access to 
257 care for rural ESLD patients that contributes to poor outcomes in this population. 
258 Our results offer an important insight into care and outcomes for patients with cirrhosis. Potential 
259 reasons for excess mortality in rural hospitals include low volume of invasive procedures17,18 and less 
260 access to subspecialists such as gastroenterologists, which has been associated with poor outcomes for 
261 liver disease patients.19-21  One immediate implication of our findings is that liver disease patients benefit 
262 from care at urban centers, either due to resources or personnel which are more commonly available than 
263 in rural settings. Previous studies have shown that rural patients prefer hospitals with greater service 
264 capacity22, and are more likely to “bypass” closer, rural hospitals for urban hospitals if they have acute 
265 medical conditions23, such as decompensated cirrhosis. While expedited transfer of ESLD patients to 
266 urban centers could potentially reduce mortality risks in the short term, such a policy would be costly and 
267 risk further partitioning quality care away from rural communities where hospital closures already 
268 threaten access to care24. A more inclusive and ultimately effective approach would be to leverage 
269 technologies such as telemedicine, which has been applied to other facets of rural healthcare delivery 
270 including preventing emergency room transfers25, providing pediatric subspecialty care26, and providing 
271 time-sensitive care to stroke patients27. Clinical decision support systems28 and regional collaborations 
272 and support networks29 have also been successfully implemented to improve quality of care and in rural 
273 hospitals. One such pilot program using Veterans Health Administration referrals to a central subspecialty 
274 service found similar survival with telepresence consultations and in-person visits, and a marked 
275 reduction in patient mortality across early and late stage liver disease in propensity-matched cohorts 
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277 shown telemedicine and spoke-and-hub referral systems to be highly cost effective in other disease 
278 settings31-33. Another strategy to contain costs and facilitate patient referral and follow-up would be the 
279 employment of patient navigators, who have been proven to reduce unnecessary emergency department 
280 visits and readmissions in other settings34,35. 
281 Our findings support those of previous studies that demonstrated the importance of hospital-level 
282 characteristics to outcomes among cirrhosis patients7,8. Mellinger et al. found that admissions to rural 
283 hospitals had 27% higher odds of in-hospital mortality than admissions to urban hospitals after 
284 accounting for patient-level factors, although in their cohort, this was effect not statistically significant.7 
285 However, this analysis was restricted to one year of data from a “high volume cohort” of hospitals, 
286 potentially skewing the association between rurality and mortality due to differential exclusion of rural 
287 hospitals with less experience treating cirrhotic patients and higher in-hospital mortality rates. Our results 
288 are also consistent with findings from other diseases, including rural-urban disparities in the quality of 
289 care and mortality rates for cardiopulmonary conditions including acute myocardial infarction, pneumonia 
290 and congestive heart failure.9,36 Disparities in inpatient care quality in the rural setting reflect 
291 environmental considerations that extend beyond the hospital itself37, but key contributors within the 
292 health system framework are lesser engagement of multidisciplinary teams outside of teaching and high-
293 volume centers38, less timely access to procedural specialists such as interventional radiologists39, and 
294 even structural considerations such as the size and experience of health care informatics and 
295 administrative staff40,41. Although the manifold drivers of rural disparity are challenging, they represent 
296 numerous domains in which quality improvement projects may identify and ameliorate excess risks in 
297 this population.
298 This analysis is constrained by limitations common to retrospective review of administrative data. 
299 Patient-specific risks are not captured in registry data, so that considerations such as clinical stability for 
300 transfer and proximity of the admitting hospital to a tertiary referral center cannot be adjusted for in 
301 models. As a sample of admissions, the NIS lacks any patient identifier to follow patients across 
302 admissions.  The re-design of the NIS after 2011 does not allow for hospital identification or linkage to 
303 other datasets. This lack of hospital identifiers restricts our ability to explore hospital-specific 
304 characteristics such as care processes that might differ between rural and urban hospitals and account for 
305 the observed disparity, as well as factors that occur before the admission (such as access to primary or 
306 specialty care). Because of these limitations, NIS data must be taken as a stand-alone depiction of 
307 hospitalization, with limited context and no ability to imply causality. Despite these constraints, however, 
308 NIS represents the largest all-payer inpatient care database in the United States, containing data on more 
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310 stage liver disease offers insights into patterns of disease and care at a level not obtainable through other 
311 data sources.
312 In conclusion, end-stage liver disease patients admitted to rural hospitals had an increased odds of 
313 in-hospital mortality compared to those admitted to urban hospitals, particularly among patients with 
314 lower APR-DRG expected mortality scores. After accounting for hospital rurality, patient-level rurality 
315 was not associated with increased in-hospital mortality. These findings suggest that excess mortality 
316 associated with rural hospitals may not be due to patient-level factors, but rather features of the admitting 
317 center. Further research is needed to identify potential hospital-level mediators and targets for improved 
318 care of liver disease patients in rural settings.
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Table 1. Demographic characteristics of end-stage liver disease (ESLD) hospital admissions in the 




(N = 555,220) %
Hospital rurality
  Rural 8,992 44,960 8.1
  Urban 102,052 510,260 91.9
Patient rurality
  Rural 17,559 87,795 15.9
  Urban 92,657 463,285 84.1
  Missing 828
Sex
  Male 72,839 364,195 65.6
  Female 38,191 190,955 34.4
  Missing 14
Race
  White 67,815 339,075 63.8
  Black 11,142 55,710 10.5
  Hispanic 18,776 93,880 17.7
  Asian/Pacific Islander 3,274 16,370 3.1
  Native American 1,476 7,380 1.4
  Other 3,820 19,100 3.6
  Missing 4,741
Primary payer
  Medicare 47,478 237,390 42.9
  Medicaid 25,089 125,445 22.6
  Private insurance 24,332 121,660 22.0
  Self-pay 8,591 42,955 7.8
  No charge 796 3,980 0.7
  Other 4,464 22,320 4.0
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  $1 - 38,999 36,073 180,365 33.5
  $39,000 - 47,999 28,388 141,940 26.4
  $48,000 - 63,999 24,389 121,945 22.6
  $64,000+ 18,884 94,420 17.5
  Missing 3,310
Hospital region
  Northeast 20,600 103,000 18.6
  Midwest 20,491 102,455 18.5
  South 44,737 223,685 40.3
  West 25,216 126,080 22.7
Hospital bed size
  Small 14,136 70,680 12.7
  Medium 29,312 146,560 26.4
  Large 67,596 337,980 60.9
APR-DRG mortality risk
  Minor risk of dying 7,122 35,610 6.4
  Moderate risk of dying 37,477 187,385 33.8
  Major risk of dying 47,565 237,825 42.8
  Severe risk of dying 18,869 94,345 17.0
  Missing 11
Died in hospital
  Yes 7,178 35,890 6.5
  No 103,823 519,115 93.5
  Missing 43
Mean Standard Deviation
Age 59.5 26.6
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Table 2. Demographic characteristics of end-stage liver disease admissions stratified by hospital-level and patient-level rurality, National 
Inpatient Sample, United States, 2012 – 2014. 
Hospital rurality Patient rurality Among rural patients
Rural 
Hospital Urban Hospital Rural Patient Urban Patient Rural Hospital Urban Hospital
N % N % p N % N % p N % N % p
Hospital rurality <0.01
  Rural 8,356 47.6 623 0.7
  Urban 9,203 52.4 92,034 99.3
Patient rurality <0.01
  Rural 8,356 93.1 9,203 9.1
  Urban 623 6.9 92,034 90.9
Sex <0.01 <0.01 <0.01
  Male 5,626 62.6 67,203 65.9
11,26
9 64.2 60,928 65.8 5,224 62.5 6,045 65.7
  Female 3,356 37.4 34,835 34.1 6,289 35.8 31,717 34.2 3,132 37.5 3,157 34.3
Race <0.01 <0.01 <0.01
  White 6,853 82.2 60,962 62.2
13,02
8 80.4 54,424 61.0 6,330 82.0 6,698 78.9
  Black 479 5.7 10,663 10.9 892 5.5 10,115 11.3 442 5.7 450 5.3
  Hispanic 566 6.8 18,210 18.6 1,262 7.8 17,324 19.4 528 6.8 734 8.7
  Asian/Pacific Islander 65 0.8 3,209 3.3 114 0.7 3,134 3.5 63 0.8 51 0.6
  Native American 237 2.8 1,239 1.3 589 3.6 886 1.0 222 2.9 367 4.3
  Other 142 1.7 3,678 3.8 319 2.0 3,403 3.8 133 1.7 186 2.2
Primary payer <0.01 <0.01 <0.01
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  Medicaid 1,852 20.7 23,237 22.8 3,524 20.2 21,271 23.0 1,724 20.7 1,800 19.7
  Private insurance 1,552 17.3 22,780 22.4 3,405 19.5 20,804 22.5 1,426 17.1 1,979 21.6
  Self-pay 652 7.3 7,939 7.8 1,344 7.7 7,120 7.7 594 7.1 750 8.2
  No charge 41 0.5 755 0.7 80 0.5 704 0.8 41 0.5 39 0.4
  Other 344 3.8 4,120 4.0 848 4.9 3,545 3.8 307 3.7 541 5.9
Median household 
income <0.01 <0.01 0.01
  $1 - 38,999 4,697 54.2 31,376 31.7 9,251 54.6 26,822 29.5 4,520 56.0 4,731 53.3
  $39,000 - 47,999 2,921 33.7 25,467 25.7 5,733 33.8 22,655 25.0 2,688 33.3 3,045 34.3
  $48,000 - 63,999 859 9.9 23,530 23.8 1,687 10.0 22,702 25.0 738 9.2 949 10.7
  $64,000+ 195 2.2 18,689 18.9 271 1.6 18,613 20.5 120 1.5 151 1.7
Hospital region <0.01 <0.01 <0.01
  Northeast 1,161 12.9 19,439 19.0 1,594 9.1 18,674 20.2 1,032 12.4 562 6.1
  Midwest 1,912 21.3 18,579 18.2 4,234 24.1 16,221 17.5 1,829 21.9 2,405 26.1
  South 4,706 52.3 40,031 39.2 9,338 53.2 35,146 37.9 4,330 51.8 5,008 54.4
  West 1,213 13.5 24,003 23.5 2,393 13.6 22,616 24.4 1,165 13.9 1,228 13.3
Hospital bed size <0.01 <0.01
  Small 995 11.1 13,141 12.9 1,735 9.9 12,336 13.3 917 11.0 818 8.9
  Medium 1,798 20.0 27,514 27.0 3,884 22.1 25,243 27.2 1,664 19.9 2,220 24.1
  Large 6,199 68.9 61,397 60.2
11,94
0 68.0 55,078 59.4 5,775 69.1 6,165 67.0
APR-DRG mortality 
risk <0.01 <0.01 <0.01
  Minor risk of dying 830 9.2 6,292 6.2 1,237 7.0 5,825 6.3 781 9.4 456 5.0
  Moderate risk of dying 3,525 39.2 33,952 33.3 6,089 34.7 31,106 33.6 3,283 39.3 2,806 30.5
  Major risk of dying 3,570 39.7 43,995 43.1 7,272 41.4 39,945 43.1 3,300 39.5 3,972 43.2
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Died in hospital 0.02 <0.01 0.86
  Yes 635 7.1 6,543 6.4 1,248 7.1 5,862 6.3 591 92.9 657 92.9
  No 8,353 92.9 95,470 93.6
16,30
2 92.9 86,761 93.7 7,761 7.1 8,541 7.1
Discharge location <0.01 <0.01 <0.01
   Routine 4,763 53.0 60,768 59.6
10,10
4 57.6 54,914 59.3 4,409 52.8 5,695 61.9
   Transfer to short-term 702 7.8 2,760 2.7 884 5.0 2,561 2.8 649 7.8 235 2.6
   Transfer to SNF, ICF, 
other 1,427 15.9 14,933 14.6 2,525 14.4 13,748 14.8 1,353 16.2 1,172 12.7
   Home health 1,298 14.4 14,827 14.5 2,523 14.4 13,502 14.6 1,197 14.3 1,327 14.4
   AMA 148 1.7 2,032 2.0 248 1.4 1,888 2.0 140 1.7 108 1.2
   Died 635 7.1 6,543 6.4 1,248 7.1 5,862 6.3 591 7.1 657 7.1
Portal hypertensive 
complication
   Portal hypertension 2,489 27.7 38,598 37.8 <0.01 6,139 35.0 34,645 37.4 <0.01 2,301 27.5 3,838 41.7 <0.01
   Ascites 4,177 46.5 50,464 49.5 <0.01 8,593 48.9 45,654 49.3 0.42 3,860 46.2 4,733 51.4 <0.01
   Hepatic 
encephalopathy 3,901 43.4 34,557 33.9 <0.01 6,775 38.6 31,476 34.0 <0.01 3,645 43.6 3,130 34.0 <0.01
   Upper gastrointestinal 
bleed 1,652 18.4 17,347 17.0 0.01 3,212 18.3 15,627 16.9 <0.01 1,534 18.4 1,678 18.2 0.83
   Hepatorenal syndrome 518 5.8 6,609 6.5 0.01 1,188 6.8 5,893 6.4 0.04 486 5.8 702 7.6 <0.01
Primary liver tumor 1,631 18.1 29,490 28.9 <0.01 3,984 22.7 26,839 29.0 <0.01 1,524 18.2 2,460 26.7 <0.01
Mean SD Mean SD p Mean SD Mean SD p Mean SD Mean SD p
Length of stay, in days 4.4 4.5 5.6 6.9 <0.01 5.2 5.8 5.6 6.9 <0.01 4.4 4.4 5.9 6.7 <0.01
Age, in years 60.7 11.8 59.4 11.9 <0.01 59.7 11.8 59.5 11.9 0.04 60.7 11.8 58.8 11.8 <0.01
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Figure 1.  Proportion of admissions for ESLD patients that died in the hospital, stratified by disease 
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Model 1A/B 1 Model 22 Model  33 Model 44
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Minor risk of dying
   Rural hospital 2.47 1.44, 4.22 1.35 0.63, 2.91 2.73 1.20, 6.20 2.67 1.18, 6.07
   Urban hospital Ref Ref Ref Ref Ref Ref Ref Ref
   Rural patient 2.44 1.50, 3.96 1.99 1.00, 4.00 1.36 0.64, 2.92 1.36 0.64, 2.90
   Urban patient Ref Ref Ref Ref Ref Ref Ref Ref
Moderate risk of dying
   Rural hospital 2.34 1.82, 3.00 2.12 1.47, 3.05 2.39 1.61, 3.58 2.15 1.43, 3.23
   Urban hospital Ref Ref Ref Ref Ref Ref Ref Ref
   Rural patient 1.8 1.44, 2.26 1.14 0.82, 1.58 1.05 0.72, 1.54 1.05 0.71, 1.55
   Urban patient Ref Ref Ref Ref Ref Ref Ref Ref
Major risk of dying
   Rural hospital 2.11 1.82, 2.44 2.16 1.75, 2.66 2.48 1.97, 3.14 2.29 1.81, 2.89
   Urban hospital Ref Ref Ref Ref Ref Ref Ref Ref
   Rural patient 1.47 1.29, 1.66 0.97 0.82, 1.17 0.89 0.73, 1.10 0.91 0.74, 1.12
   Urban patient Ref Ref Ref Ref Ref Ref Ref Ref
Extreme risk of 
dying
   Rural hospital 1.15 1.00, 1.31 1.23 1.05, 1.45 1.32 1.01, 1.57 1.23 1.03, 1.47
   Urban hospital Ref Ref Ref Ref Ref Ref Ref Ref
   Rural patient 0.99 0.91, 1.08 0.92 0.83, 1.02 0.91 0.81, 1.03 0.92 0.82, 1.05
   Urban patient Ref Ref Ref Ref Ref Ref Ref Ref
Table 3. Multivariable logistic regression examining effect of rurality on in-hospital mortality 
among admissions for end-stage liver disease, 2012 – 2014. 
1 Model includes either hospital-level or patient-level rurality. 
2 Model includes both hospital-level and patient-level rurality. 
3 Model includes hospital-level rurality, patient-level rurality, age, gender, race, primary payer, income 
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4 Model includes hospital-level rurality, patient-level rurality, age, gender, race, primary payer, income 
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Table 4. Receipt of procedures among admissions for end-stage liver disease by hospital rurality in the National Inpatient Sample, 2012 – 
2014. 
Paracentesis Endoscopy Either
Rural Urban Rural Urban Rural Urban
N % N % p-value N % N % p-value N % N % p-value
Minor risk of dying 0.50 0.02 0.06
   Procedure 109 13.1 880 14.0 40 4.8 434 6.9 148 17.8 1300 20.7
   No procedure 721 86.9 5412 86.0 790 95.2 5858 93.1 682 82.2 4992 79.3
Moderate risk of 
dying <0.001 <0.001 <0.001
   Procedure 957 27.1 11343 33.4 329 9.3 5545 16.3 1217 34.5 15703 46.3
   No procedure 2568 72.9 22609 66.6 3196 90.7 28407 83.7 2308 65.5 18249 53.7
Major risk of dying <0.001 <0.001 <0.001
   Procedure 979 27.4 14634 33.3 662 18.5 10771 24.5 1516 42.5 22608 51.4
   No procedure 2591 72.6 29361 66.7 2908 81.5 33224 75.5 2054 57.5 21387 48.6
Extreme risk of 
dying <0.001 <0.001 <0.001
   Procedure 361 33.8 7492 42.1 183 17.2 4622 26.0 498 46.7 10229 57.5
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